Evidence map›Paper›PMID 37325394›Full record

ArticleACS catalysis2022

In-depth Sequence-Function Characterization Reveals Multiple Pathways to Enhance Enzymatic Activity.

Vikas D Trivedi, Todd C Chappell, Naveen B Krishna, Anuj Shetty, Gladstone G Sigamani, Karishma Mohan, Athreya Ramesh, Kumar R Pravin, Nikhil U Nair

Open access · greenAbstract read
In one paragraph

Article in ACS catalysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Vikas D TrivediDepartment of Chemical and Biological Engineering, Tufts University, Medford, USA 02155.
Todd C ChappellDepartment of Chemical and Biological Engineering, Tufts University, Medford, USA 02155.
Naveen B KrishnaKcat Enzymatic Private Limited, Bengaluru, Karnataka, India 560005.
Anuj ShettyKcat Enzymatic Private Limited, Bengaluru, Karnataka, India 560005.
Gladstone G SigamaniKcat Enzymatic Private Limited, Bengaluru, Karnataka, India 560005.
Karishma MohanDepartment of Chemical and Biological Engineering, Tufts University, Medford, USA 02155.
Athreya RameshDepartment of Chemical and Biological Engineering, Tufts University, Medford, USA 02155.
Kumar R PravinKcat Enzymatic Private Limited, Bengaluru, Karnataka, India 560005.
Nikhil U NairDepartment of Chemical and Biological Engineering, Tufts University, Medford, USA 02155.
Tufts University · US

Funding

Metabolic engineering in humans: Altered gut microbes as a therapeutic platformDP2HD091798 · NICHD · TUFTS UNIVERSITY MEDFORD · PI NAIR, NIKHIL UNNI · 2016 to 2016
$2.3M
NICHD NIH HHS DP2 HD091798
6 · The paper itself

Abstract

Deep mutational scanning (DMS) has recently emerged as a powerful method to study protein sequence-function relationships but it has not been well-explored as a guide to enzyme engineering and identifying pathways by which their catalytic cycle may be improved. We report such a demonstration in this work using a Phenylalanine ammonia-lyase (PAL), which deaminates L-phenylalanine to

Indexed as

deep mutational scanningdirected evolutionmolecular dynamicsPALphenylalanine ammonia-lyasephenylketonuriaPKUQM/MM

Identifiers

PMID37325394
PMCPMC10270700
OpenAlexW4210591445

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.